Annual Operating Expenses
$11.81 M
-$3.68 M-23.74%
01 December 2023
Summary:
NLS Pharmaceutics AG annual total operating expenses is currently $11.81 million, with the most recent change of -$3.68 million (-23.74%) on 01 December 2023. During the last 3 years, it has risen by +$9.51 million (+413.49%). NLSP annual operating expenses is now -23.74% below its all-time high of $15.48 million, reached on 31 December 2022.NLSP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.7% | - |
3 y3 years | +413.5% | - |
5 y5 years | +242.3% | - |
NLSP Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -23.7% | +413.5% | ||
5 y | 5 years | -23.7% | +413.5% | ||
alltime | all time | -23.7% | +413.5% |
NLS Pharmaceutics AG Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $11.81 M(-23.7%) | - |
Dec 2022 | $15.48 M(+30.5%) | - |
Dec 2021 | $11.86 M(+415.8%) | - |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $2.30 M(-45.2%) | - |
Dec 2019 | $4.20 M(+21.7%) | - |
Dec 2018 | $3.45 M(-40.2%) | - |
Dec 2017 | $5.77 M | - |
FAQ
- What is NLS Pharmaceutics AG annual total operating expenses?
- What is the all time high annual operating expenses for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual operating expenses year-on-year change?
What is NLS Pharmaceutics AG annual total operating expenses?
The current annual operating expenses of NLSP is $11.81 M
What is the all time high annual operating expenses for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual total operating expenses is $15.48 M
What is NLS Pharmaceutics AG annual operating expenses year-on-year change?
Over the past year, NLSP annual total operating expenses has changed by -$3.68 M (-23.74%)